ALLC and phenylketonuria: Although the BH4 levels could not be measured directly in the above treatments due to the lack of standards, the detection of gene expressions and metabolic substances imply that silkworm alc mutant and human BH4-deficient PKU have a high similarity in the drug metabolic features and the BH4 biosynthesis pathway, as well as in the downstream dopamine metabolic pathway.